Liphatech Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Chemicals

Industry

Employee Data

  • Liphatech has 112 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A2N/AN/AN/A
#2
N/A40N/AN/AN/A
#3
N/A125-1%N/AN/A
#4
N/A57-5%N/AN/A
#5
N/A47-2%N/AN/A
#6
N/A2353%N/AN/A
#7
N/A112N/AN/AN/A
#8
$1370M19284%N/AN/A
#9
N/A84-5%N/AN/A
#10
N/A1230%N/AN/A

At LIPHATECH, we're not just scientists, biologists and marketers. We're problem solvers. We understand the issues facing the industries we serve and use our insight to develop new technologies and solutions. In short, we combine our resources with other manufacturers to produce new products that help improve the human environment worldwide. LIPHATECH is the world's leading developer of rodent control products. We're protecting people and property from unwanted pests. LIPHATECH is a company that uses advanced chemistry and biology to improve the quality of life. LIPHATECH invests time, talent and resources in the development, manufacturing and marketing of exceptional products - either bringing them to market ourselves or through strategic partnerships - around the world.

keywords:N/A

N/A

Total Funding

112

Number of Employees

N/A

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Liphatech News

2022-04-20 - Non-Anti Coagulant Rodenticides Market Strategic ...

... Strategic Assessment & SWOT Analysis 2021-2028 | BASF SE, Bayer AG, Syngenta, SenesTech, Inc., UPL, NEOGEN CORPORATION, Liphatech, Inc.,.

2022-04-20 - Rodenticides Market Size, Scope And Outlook | BASF SE ...

Liphatech Neogen Corporation, Pelgar International, Senestech Syngenta SA, UPL Limited. Market factors could use prospect information to...

2022-04-13 - Liphatech Promotes Titshaw to Business Manager of ...

Matt Titshaw will be the strategic lead for all pest management industry sales of Liphatech product lines in the U.S. and Canada.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.2M112-16%N/A
#2
$36.2M11213%N/A
#3
$11.1M11320%N/A
#4
$16.4M1133%N/A
#5
$23.7M11320%N/A